These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2994992)

  • 1. [Human breast cancer markers].
    Remennik LV
    Eksp Onkol; 1985; 7(4):3-8. PubMed ID: 2994992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tissue polypeptide antigen in breast cancer].
    Nomizu T; Watanabe I; Endo S
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2287-95. PubMed ID: 6085339
    [No Abstract]   [Full Text] [Related]  

  • 3. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
    Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor markers in ovarian cancer].
    Lahousen M
    Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
    [No Abstract]   [Full Text] [Related]  

  • 5. Usefulness of clinical chemistry measurements in classifying patients with breast cancer.
    Statland BE; Winkel P
    Crit Rev Clin Lab Sci; 1982; 16(4):255-90. PubMed ID: 6749428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing tumor markers in breast cancer: monitoring, prognosis, and therapy control.
    Staab HJ; Ahlemann LM; Anderer FA; Zwirner M; Schindler AE
    Cancer Detect Prev; 1985; 8(1-2):35-45. PubMed ID: 4064050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunomorphologic markers in breast cancer].
    Volchenko NN; Litvinova LV; Pugachev KK; Shimbireva IB; Kalashnikov VV; Frank GA
    Arkh Patol; 1996; 58(1):6-10. PubMed ID: 8929144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor markers in breast cancer (review).
    Jotti GS; Bombardieri E
    Anticancer Res; 1990; 10(1):253-8. PubMed ID: 2185687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tissue polypeptide antigen in thyroid cancer].
    Nomizu T; Watanabe I; Endo S
    Nihon Gan Chiryo Gakkai Shi; 1984 Jul; 19(6):1289-95. PubMed ID: 6595323
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of tumor markers in breast cancer patients].
    Ito T; Tanaka S; Ban K; Sakai N; Oshita H; Oiwa T; Kanno A; Kashizuka T
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2917-23. PubMed ID: 3310907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
    Kausitz J; Hupka S; Makaiová I; Michalíková B; Urbanová M; Bohunický L; Belovicová C
    Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and prognosis of breast lesions. Value of 3 immunological markers: fibronectin, carcinoembryonic antigen and bovine lactalbumin. Study of 40 cases].
    Canioni D; Kermarec J
    Arch Anat Cytol Pathol; 1984; 32(4):235-42. PubMed ID: 6508376
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tumor markers in human breast cancer].
    Takami H; Shikata J
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):2998-3003. PubMed ID: 3479050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor markers in breast cancer].
    Polevaia EB; Tkacheva GA; Letiagin VP; Ivanov VM; Koposova TL
    Sov Med; 1985; (3):25-9. PubMed ID: 4023831
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor associated markers in breast cancer.
    Franchimont P; Zangerle PF; Colin C; Osterrieth P; Hendrick JC; van Cauwenberge JR; Hustin J
    Eur J Cancer (1965); 1980; Suppl 1():17-20. PubMed ID: 6172278
    [No Abstract]   [Full Text] [Related]  

  • 17. [Predictive value of a tumor marker combination for the monitoring of ovarian cancer].
    Lahousen M
    Wien Klin Wochenschr; 1986 May; 98(10):319-25. PubMed ID: 3460273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncofetal and oncoplacental antigens as tumor markers.
    Yamauchi S; Miyake H
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical utility of tumor markers in gastric and colon cancer].
    Ogawa K; Naritaka Y; Koyama N; Ohtani Y; Kawata H; Yagawa H; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1985 May; 31(6 Suppl):638-47. PubMed ID: 3861884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ferritin, CEA and TPA as tumor markers in breast neoplasms].
    Bonanni F; Folco U; Giudici Cipriani A; Buffa E; Amedeo A; Bertolotto M; Rembado R; Barbetti V; Guglieri F
    Minerva Med; 1985 Sep; 76(34-35):1533-4. PubMed ID: 4034052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.